Granulocyte monocyte-colony stimulating factor as an agent for wound healing. A study evaluating the use of local injections of a genetically engineered growth factor in the management of wounds with a poor healing prognosis.
Arnold
F
F
O'Brien
J
J
Cherry
G
G
D000368:Aged; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007871:Leg Ulcer / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use*; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects*
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor